β-Amyloid regulates leptin expression and tau phosphorylation through the mTORC1 signaling pathway

Journal of Neurochemistry

Volumn 115, Issue 2, 2010, Pages 373-384

  Marwarha, Gurdeep ^a   Dasari, Bhanu ^a   Prabhakara, Jaya Prasanthi Rantham ^a   Schommer, Jared ^a   Ghribi, Othman ^a  

^a UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Amyloid; Alzheimer's disease; Leptin; MTOR; Organotypic slices; Tau

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; GLYCOGEN SYNTHASE KINASE 3BETA; LEPTIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; PROTEIN KINASE B; RAPAMYCIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TAU PROTEIN;

ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; HIPPOCAMPUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RABBIT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; HIPPOCAMPUS; IMMUNOSUPPRESSIVE AGENTS; LEPTIN; MALE; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RABBITS; RECEPTORS, LEPTIN; SIGNAL TRANSDUCTION; SIROLIMUS; STATISTICS, NONPARAMETRIC; TAU PROTEINS; TOR SERINE-THREONINE KINASES;

MAMMALIA; ORYCTOLAGUS CUNICULUS;

EID: 78651277918     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2010.06929.x     Document Type: Article

References (68)

1. Bjorbaek C., El-Haschimi K., Frantz J. D. and Flier J. S. (1999) The role of SOCS-3 in leptin signaling and leptin resistance. J. Biol. Chem. 274, 30059-30065.
2. Brown E. J., Beal P. A., Keith C. T., Chen J., Shin T. B. and Schreiber S. L. (1995) Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 377, 441-446.
3. Brownlees J., Irving N. G., Brion J. P., Gibb B. J., Wagner U., Woodgett J. and Miller C. C. (1997) Tau phosphorylation in transgenic mice expressing glycogen synthase kinase-3beta transgenes. Neuroreport 8, 3251-3255.
4. Chakrabarti P., Anno T., Manning B. D., Luo Z. and Kandror K. V. (2008) The mammalian target of rapamycin complex 1 regulates leptin biosynthesis in adipocytes at the level of translation: The role of the 5'-untranslated region in the expression of leptin messenger ribonucleic acid. Mol. Endocrinol. 22, 2260-2267.
5. Chen T. J., Wang D. C. and Chen S. S. (2009) Amyloid-beta interrupts the PI3K-Akt-mTOR signaling pathway that could be involved in brain-derived neurotrophic factor-induced Arc expression in rat cortical neurons. J. Neurosci. Res. 87, 2297-2307.
6. Cho H. J., Park J., Lee H. W., Lee Y. S. and Kim J. B. (2004) Regulation of adipocyte differentiation and insulin action with rapamycin. Biochem. Biophys. Res. Commun. 321, 942-948.
7. Cota D., Proulx K., Smith K. A., Kozma S. C., Thomas G., Woods S. C. And Seeley R. J. (2006) Hypothalamic mTOR signaling regulates food intake. Science 312, 927-930.
8. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M. and Hemmings B. A. (1995) Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378, 785-789.
9. Dajani R., Fraser E., Roe S. M., Young N., Good V., Dale T. C. and Pearl L. H. (2001) Crystal structure of glycogen synthase kinase 3 beta: Structural basis for phosphate-primed substrate specificity and autoinhibition. Cell 105, 721-732.
10. Farr S. A., Banks W. A. and Morley J. E. (2006) Effects of leptin on memory processing. Peptides 27, 1420-1425.
11. Fewlass D. C., Noboa K., Pi-Sunyer F. X., Johnston J. M., Yan S. D. and Tezapsidis N. (2004) Obesity-related leptin regulates Alzheimer's Abeta. FASEB J. 18, 1870-1878.
12. Freir D. B., Holscher C. and Herron C. E. (2001) Blockade of long-term potentiation by beta-amyloid peptides in the CA1 region of the rat hippocampus in vivo. J. Neurophysiol. 85, 708-713.
13. Ghribi O., Herman M. M. and Savory J. (2003a) Lithium inhibits Abetainduced stress in endoplasmic reticulum of rabbit hippocampus but does not prevent oxidative damage and tau phosphorylation. J. Neurosci. Res. 71, 853-862.
14. Ghribi O., Prammonjago P., Herman M. M., Spaulding N. K. and Savory J. (2003b) Abeta(1-42)-induced JNK and ERK activation in rabbit hippocampus is differentially regulated by lithium but is not involved in the phosphorylation of tau. Brain Res. Mol. Brain Res. 119, 201-206.
15. Graur D., Duret L. and Gouy M. (1996) Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature 379, 333-335.
16. Greco S. J., Sarkar S., Johnston J. M., Zhu X., Su B., Casadesus G., Ashford J. W., Smith M. A. and Tezapsidis N. (2008) Leptin reduces Alzheimer's disease-related tau phosphorylation in neuronal cells. Biochem. Biophys. Res. Commun. 376, 536-541.
17. Greco S. J., Sarkar S., Casadesus G., Zhu X., Smith M. A., Ashford J. W., Johnston J. M. and Tezapsidis N. (2009a) Leptin inhibits glycogen synthase kinase-3beta to prevent tau phosphorylation in neuronal cells. Neurosci. Lett. 455, 191-194.
18. Greco S. J., Sarkar S., Johnston J. M. and Tezapsidis N. (2009b) Leptin regulates tau phosphorylation and amyloid through AMPK in neuronal cells. Biochem. Biophys. Res. Commun. 380, 98-104.
19. Greco S. J., Bryan K. J., Sarkar S., Zhu X., Smith M. A., Ashford J. W., Johnston J. M., Tezapsidis N. and Casadesus G. (2010) Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease. J. Alzheimers. Dis. 19, 1155-1167.
20. Guo Z., Jiang H., Xu X., Duan W. and Mattson M. P. (2008) Leptinmediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J. Biol. Chem. 283, 1754-1763.
21. Hanger D. P., Hughes K., Woodgett J. R., Brion J. P. and Anderton B. H. (1992) Glycogen synthase kinase-3 induces Alzheimer's diseaselike phosphorylation of tau: Generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 147, 58-62.
22. Hara K., Maruki Y., Long X., Yoshino K., Oshiro N., Hidayat S., Tokunaga C., Avruch J. and Yonezawa K. (2002) Raptor, a binding partner of target of rapamycin (TOR), mediates TOR action. Cell 110, 177-189.
23. Hardy J. and Selkoe D. J. (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356.
24. Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M. A., Hall A. and Hall M. N. (2004) Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 6, 1122-1128.
25. Johnstone E. M., Chaney M. O., Norris F. H., Pascual R. and Little S. P. (1991) Conservation of the sequence of the Alzheimer's disease amyloid peptide in dog, polar bear and five other mammals by cross-species polymerase chain reaction analysis. Brain Res. Mol. Brain Res. 10, 299-305.
26. Karpova A., Sanna P. P. and Behnisch T. (2006) Involvement of multiple phosphatidylinositol 3-kinase-dependent pathways in the persistence of late-phase long term potentiation expression. Neuroscience 137, 833-841.
27. Kelly A. and Lynch M. A. (2000) Long-term potentiation in dentate gyrus of the rat is inhibited by the phosphoinositide 3-kinase inhibitor, wortmannin. Neuropharmacology 39, 643-651.
28. Kim D. H., Sarbassov D. D., Ali S. M., King J. E., Latek R. R., Erdjument- Bromage H., Tempst P. and Sabatini D. M. (2002) mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell 110, 163-175.
29. Lafay-Chebassier C., Paccalin M., Page G., Barc-Pain S., Perault-Pochat M. C., Gil R., Pradier L. and Hugon J. (2005) mTOR/p70S6k signalling alteration by Abeta exposure as well as in APP-PS1 transgenic models and in patients with Alzheimer's disease. J. Neurochem. 94, 215-225.
30. Lafay-Chebassier C., Perault-Pochat M. C., Page G., Rioux B. A., Damjanac M., Pain S., Houeto J. L., Gil R. and Hugon J. (2006) The immunosuppressant rapamycin exacerbates neurotoxicity of Abeta peptide. J. Neurosci. Res. 84, 1323-1334.
31. Leroy K., Yilmaz Z. and Brion J. P. (2007) Increased level of active GSK-3beta in Alzheimer's disease and accumulation in argyrophilic grains and in neurones at different stages of neurofibrillary degeneration. Neuropathol. Appl. Neurobiol. 33, 43-55.
32. Li H. Y., Wang L. L. and Yeh R. S. (1999) Leptin immunoreactivity in the central nervous system in normal and diabetic rats. Neuroreport 10, 437-442.
33. Lieb W., Beiser A. S., Vasan R. S. et al. (2009) Association of plasma leptin levels with incident Alzheimer disease and MRI measures of brain aging. JAMA 302, 2565-2572.
34. Liu F., Grundke-Iqbal I., Iqbal K. and Gong C. X. (2005) Contributions of protein phosphatases PP1, PP2A, PP2B and PP5 to the regulation of tau phosphorylation. Eur. J. Neurosci. 22, 1942-1950.
35. Loewith R., Jacinto E., Wullschleger S., Lorberg A., Crespo J. L., Bonenfant D., Oppliger W., Jenoe P. and Hall M. N. (2002) Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control. Mol. Cell 10, 457-468.
36. Lovestone S., Reynolds C. H., Latimer D., Davis D. R., Anderton B. H., Gallo J. M., Hanger D., Mulot S., Marquardt B. and Stabel S. (1994) Alzheimer's disease-like phosphorylation of the microtubule- associated protein tau by glycogen synthase kinase-3 in transfected mammalian cells. Curr. Biol. 4, 1077-1086.
37. Lucas J. J., Hernandez F., Gomez-Ramos P., Moran M. A., Hen R. and Avila J. (2001) Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice. EMBO J. 20, 27-39.
38. Ludwig M., Klein H. H., Diedrich K. and Ortmann O. (2000) Serum leptin concentrations throughout the menstrual cycle. Arch. Gynecol. Obstet. 263, 99-101.
39. Magrane J., Rosen K. M., Smith R. C., Walsh K., Gouras G. K. and Querfurth H. W. (2005) Intraneuronal beta-amyloid expression downregulates the Akt survival pathway and blunts the stress response. J. Neurosci. 25, 10960-10969.
40. Mandelkow E. M., Drewes G., Biernat J., Gustke N., Van L. J., Vandenheede J. R. and Mandelkow E. (1992) Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett. 314, 315-321.
41. Martin K. A. and Blenis J. (2002) Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv. Cancer Res. 86, 1-39.
42. Marwarha G., Dasari B., Prasanthi J. R., Schommer J. and Ghribi O. (2010) Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. J. Alzheimers Dis. 19, 1007-1019.
43. Maya-Monteiro C. M., Almeida P. E., D'Avila H., Martins A. S., Rezende A. P., Castro-Faria-Neto H. and Bozza P. T. (2008) Leptin induces macrophage lipid body formation by a phosphatidylinositol 3-kinase- and mammalian target of rapamycin-dependent mechanism. J. Biol. Chem. 283, 2203-2210.
44. Nassif M., Hoppe J., Santin K., Frozza R., Zamin L. L., Simao F., Horn A. P. and Salbego C. (2007) Beta-amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK- 3beta, and PTEN. Neurochem. Int. 50, 229-235.
45. Patrick G. N., Zukerberg L., Nikolic M., de la M. S., Dikkes P. and Tsai L. H. (1999) Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration. Nature 402, 615-622.
46. Peterson R. T., Beal P. A., Comb M. J. and Schreiber S. L. (2000) FKBP12-rapamycin-associated protein (FRAP) autophosphorylates at serine 2481 under translationally repressive conditions. J. Biol. Chem. 275, 7416-7423.
47. Power D. A., Noel J., Collins R. and O'Neill D. (2001) Circulating leptin levels and weight loss in Alzheimer's disease patients. Dement. Geriatr. Cogn. Disord. 12, 167-170.
48. QianW., Shi J., Yin X., Iqbal K., Grundke-Iqbal I., Gong C. X. and Liu F. (2010) PP2A regulates tau phosphorylation directly and also indirectly via activating GSK-3beta. J. Alzheimers Dis. 19, 1221-1229.
49. Rankin C. A., Sun Q. and Gamblin T. C. (2007) Tau phosphorylation by GSK-3beta promotes tangle-like filament morphology. Mol. Neurodegener. 2, 12.
50. Raymond C. R., Redman S. J. and Crouch M. F. (2002) The phosphoinositide 3-kinase and p70 S6 kinase regulate long-term potentiation in hippocampal neurons. Neuroscience 109, 531-536.
51. Riad-Gabriel M. G., Jinagouda S. D., Sharma A., Boyadjian R. and Saad M. F. (1998) Changes in plasma leptin during the menstrual cycle. Eur. J. Endocrinol. 139, 528-531.
52. Roh C., Han J., Tzatsos A. and Kandror K. V. (2003) Nutrientsensing mTOR-mediated pathway regulates leptin production in isolated rat adipocytes. Am. J. Physiol. Endocrinol. Metab. 284, E322-E330.
53. Sarbassov D. D., Ali S. M., Kim D. H., Guertin D. A., Latek R. R., Erdjument-Bromage H., Tempst P. and Sabatini D. M. (2004) Rictor, a novel binding partner of mTOR, defines a rapamycininsensitive and raptor-independent pathway that regulates the cytoskeleton. Curr. Biol. 14, 1296-1302.
54. Sarbassov D. D., Ali S. M. and Sabatini D. M. (2005a) Growing roles for the mTOR pathway. Curr. Opin. Cell Biol. 17, 596-603.
55. Sarbassov D. D., Guertin D. A., Ali S. M. and Sabatini D. M. (2005b) Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307, 1098-1101.
56. Selkoe D. J. (2008) Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior. Behav. Brain Res. 192, 106-113.
57. Shanley L. J., Irving A. J. and Harvey J. (2001) Leptin enhances NMDA receptor function and modulates hippocampal synaptic plasticity. J. Neurosci. 21, RC186.
58. Sharma S., Prasanthi R. P. J., Schommer E., Feist G. and Ghribi O. (2008) Hypercholesterolemia-induced Abeta accumulation in rabbit brain is associated with alteration in IGF-1 signaling. Neurobiol. Dis. 32, 426-432.
59. Sperber B. R., Leight S., Goedert M. and Lee V. M. (1995) Glycogen synthase kinase-3 beta phosphorylates tau protein at multiple sites in intact cells. Neurosci. Lett. 197, 149-153.
60. Sutherland C., Leighton I. A. and Cohen P. (1993) Inactivation of glycogen synthase kinase-3 beta by phosphorylation: New kinase connections in insulin and growth-factor signalling. Biochem. J. 296(Pt 1), 15-19.
61. Takashima A., Honda T., Yasutake K., Michel G., Murayama O., Murayama M., Ishiguro K. and Yamaguchi H. (1998) Activation of tau protein kinase I/glycogen synthase kinase-3beta by amyloid beta peptide (25-35) enhances phosphorylation of tau in hippocampal neurons. Neurosci. Res. 31, 317-323.
62. Tanaka M., Nakaya S., Kumai T., Watanabe M., Tateishi T., Shimizu H. And Kobayashi S. (2001) Effects of estrogen on serum leptin levels and leptin mRNA expression in adipose tissue in rats. Horm. Res. 56, 98-104.
63. Tang S. J., Reis G., Kang H., Gingras A. C., Sonenberg N. and Schuman E. M. (2002) A rapamycin-sensitive signaling pathway contributes to long-term synaptic plasticity in the hippocampus. Proc. Natl Acad. Sci. USA 99, 467-472.
64. Tezapsidis N., Johnston J. M., Smith M. A. et al. (2009) Leptin: A novel therapeutic strategy for Alzheimer's disease. J. Alzheimers Dis. 16, 731-740.
65. Tischmeyer W., Schicknick H., Kraus M., Seidenbecher C. I., Staak S., Scheich H. and Gundelfinger E. D. (2003) Rapamycin-sensitive signalling in long-term consolidation of auditory cortex-dependent memory. Eur. J. Neurosci. 18, 942-950.
66. Ur E., Wilkinson D. A., Morash B. A. and Wilkinson M. (2002) Leptin immunoreactivity is localized to neurons in rat brain. Neuroendocrinology 75, 264-272.
67. Wayner M. J., Armstrong D. L., Phelix C. F. and Oomura Y. (2004) Orexin-A (Hypocretin-1) and leptin enhance LTP in the dentate gyrus of rats in vivo. Peptides 25, 991-996.
68. Zhu X., Raina A. K., Rottkamp C. A., Aliev G., Perry G., Boux H. and Smith M. A. (2001) Activation and redistribution of c-jun N-terminal kinase/stress activated protein kinase in degenerating neurons in Alzheimer's disease. J. Neurochem. 76, 435-441.